Benign Prostatic Hyperplasia

5-ARIs Linked With Depression, But Not Suicide Risk

Publish Date January 5, 2023

This Swedish population-based study has the largest sample size to date exploring these associations.

Poor Sleep Tied to Urinary, Prostate Symptoms

Publish Date December 12, 2022

Association especially strong among the elderly male population

Lipid Ratios Linked to Benign Prostatic Hyperplasia Risk

Publish Date November 18, 2022

TG/HDL-C and TC/HDL-C ratios associated with BPH; TG/HDL-C may be risk factor for BPH with normal TG, HDL-C

Drug Repurposing Study Shows PDE5 Inhibitors Do Not Reduce Dementia Risk

Publish Date October 14, 2022

By identifying existing medications that may be repurposed for dementia, clinicians may be able to provide faster treatment for those in need.

Erectile Function Mostly Not Impacted by Surgery for BPH

Publish Date September 22, 2022

But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia

Urethral Dilation Prior to BPH Surgery Lowers Urethral Stricture Risk

Publish Date September 9, 2022

Investigators in South Korea demonstrated the benefit in a retrospective study that included 651 men undergoing transurethral resection of the prostate.

Long-Term Outcomes of ThuLEP Reported for Benign Prostatic Enlargement

Publish Date September 7, 2022

Rates of reinterventions low for persistence or regrowth of prostate adenoma, long-term complications.

Use of 5-ARIs May Decrease Bladder Cancer Risk

Publish Date May 15, 2022

A study examined bladder cancer risk and mortality among nearly 100,000 men from Ontario, Canada, who received 5-alpha reductase inhibitors.

Water Vapor Therapy for BPH Safe, Effective in Large Real-World Study

Publish Date May 14, 2022

Rezūm therapy significantly improved symptoms, urinary flow, and quality of life in men across a wide range of prostate sizes, data show.

Rise in Prostatic Urethral Lift Use for BPH Reported

Publish Date May 13, 2022

The procedure is now performed in one-third of all surgeries for benign prostatic hyperplasia, a study found.